The crescendo of outrage at the health care system lately has some arguably valid complaints. Take insulin for example. Affordable insulin is so hard to come by in the U.S. that people turn to underground networks of shared medicines, ration their own supply to cut costs, or sometimes cross the border to Mexico or Canada to get the medication they need.
Pharmaceutical companies recently introduced price caps on insulin after coming under scrutiny for charging hundreds of dollars per vial, which could be purchased in Canada for roughly one-tenth the price. About 8 million people in the U.S. with diabetes rely on insulin, and its high prices have become emblematic of what many see as a broken health care system.
